vs

Side-by-side financial comparison of Traeger, Inc. (COOK) and Orthofix Medical Inc. (OFIX). Click either name above to swap in a different company.

Orthofix Medical Inc. is the larger business by last-quarter revenue ($219.9M vs $145.4M, roughly 1.5× Traeger, Inc.). Orthofix Medical Inc. runs the higher net margin — -1.0% vs -11.8%, a 10.8% gap on every dollar of revenue. On growth, Orthofix Medical Inc. posted the faster year-over-year revenue change (2.0% vs -13.8%). Orthofix Medical Inc. produced more free cash flow last quarter ($16.8M vs $14.2M). Over the past eight quarters, Orthofix Medical Inc.'s revenue compounded faster (8.0% CAGR vs 0.2%).

Traeger, Inc. designs, manufactures, and sells premium wood pellet grills, related accessories, and wood pellet fuel for outdoor cooking users. It primarily operates in North America, Europe, and Australia, serving residential consumers and commercial food service clients via retail partners and direct-to-consumer channels.

Orthofix Medical Inc. is a global medical device firm specializing in orthopedic care. It develops, manufactures and sells spinal implants, trauma care products, bone growth stimulation therapies and regenerative medicine offerings, serving orthopedic surgeons and healthcare providers across North America, Europe and Asia Pacific.

COOK vs OFIX — Head-to-Head

Bigger by revenue
OFIX
OFIX
1.5× larger
OFIX
$219.9M
$145.4M
COOK
Growing faster (revenue YoY)
OFIX
OFIX
+15.8% gap
OFIX
2.0%
-13.8%
COOK
Higher net margin
OFIX
OFIX
10.8% more per $
OFIX
-1.0%
-11.8%
COOK
More free cash flow
OFIX
OFIX
$2.6M more FCF
OFIX
$16.8M
$14.2M
COOK
Faster 2-yr revenue CAGR
OFIX
OFIX
Annualised
OFIX
8.0%
0.2%
COOK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
COOK
COOK
OFIX
OFIX
Revenue
$145.4M
$219.9M
Net Profit
$-17.2M
$-2.2M
Gross Margin
37.4%
71.1%
Operating Margin
-8.0%
0.2%
Net Margin
-11.8%
-1.0%
Revenue YoY
-13.8%
2.0%
Net Profit YoY
-147.2%
92.4%
EPS (diluted)
$-0.13
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COOK
COOK
OFIX
OFIX
Q4 25
$145.4M
$219.9M
Q3 25
$125.4M
$205.6M
Q2 25
$145.5M
$203.1M
Q1 25
$143.3M
$193.6M
Q4 24
$168.6M
$215.7M
Q3 24
$122.0M
$196.6M
Q2 24
$168.5M
$198.6M
Q1 24
$144.9M
$188.6M
Net Profit
COOK
COOK
OFIX
OFIX
Q4 25
$-17.2M
$-2.2M
Q3 25
$-89.8M
$-22.8M
Q2 25
$-7.4M
$-14.1M
Q1 25
$-778.0K
$-53.1M
Q4 24
$-7.0M
$-29.1M
Q3 24
$-19.8M
$-27.4M
Q2 24
$-2.6M
$-33.4M
Q1 24
$-4.7M
$-36.0M
Gross Margin
COOK
COOK
OFIX
OFIX
Q4 25
37.4%
71.1%
Q3 25
38.7%
72.2%
Q2 25
39.2%
68.7%
Q1 25
41.5%
62.8%
Q4 24
40.9%
69.0%
Q3 24
42.3%
68.7%
Q2 24
42.9%
67.8%
Q1 24
43.2%
67.5%
Operating Margin
COOK
COOK
OFIX
OFIX
Q4 25
-8.0%
0.2%
Q3 25
-66.5%
-8.3%
Q2 25
-4.2%
-7.9%
Q1 25
2.4%
-25.2%
Q4 24
-0.1%
-5.3%
Q3 24
-6.1%
-9.6%
Q2 24
2.8%
-12.5%
Q1 24
-0.1%
-15.6%
Net Margin
COOK
COOK
OFIX
OFIX
Q4 25
-11.8%
-1.0%
Q3 25
-71.6%
-11.1%
Q2 25
-5.1%
-6.9%
Q1 25
-0.5%
-27.4%
Q4 24
-4.1%
-13.5%
Q3 24
-16.2%
-13.9%
Q2 24
-1.5%
-16.8%
Q1 24
-3.2%
-19.1%
EPS (diluted)
COOK
COOK
OFIX
OFIX
Q4 25
$-0.13
$-0.05
Q3 25
$-0.67
$-0.57
Q2 25
$-0.06
$-0.36
Q1 25
$-0.01
$-1.35
Q4 24
$-0.06
$-0.76
Q3 24
$-0.15
$-0.71
Q2 24
$-0.02
$-0.88
Q1 24
$-0.04
$-0.95

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COOK
COOK
OFIX
OFIX
Cash + ST InvestmentsLiquidity on hand
$19.6M
$82.0M
Total DebtLower is stronger
$403.3M
Stockholders' EquityBook value
$170.8M
$450.0M
Total Assets
$676.0M
$850.6M
Debt / EquityLower = less leverage
2.36×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COOK
COOK
OFIX
OFIX
Q4 25
$19.6M
$82.0M
Q3 25
$5.9M
$62.9M
Q2 25
$10.3M
$65.6M
Q1 25
$12.0M
$58.0M
Q4 24
$15.0M
$83.2M
Q3 24
$16.9M
$30.1M
Q2 24
$18.0M
$26.4M
Q1 24
$23.6M
$27.0M
Total Debt
COOK
COOK
OFIX
OFIX
Q4 25
$403.3M
Q3 25
$157.2M
Q2 25
$157.0M
Q1 25
$156.9M
Q4 24
$403.6M
$157.0M
Q3 24
$118.5M
Q2 24
$118.0M
Q1 24
$118.2M
Stockholders' Equity
COOK
COOK
OFIX
OFIX
Q4 25
$170.8M
$450.0M
Q3 25
$186.1M
$442.5M
Q2 25
$274.2M
$458.3M
Q1 25
$279.6M
$458.3M
Q4 24
$276.4M
$503.1M
Q3 24
$279.8M
$525.9M
Q2 24
$297.3M
$546.0M
Q1 24
$294.6M
$570.3M
Total Assets
COOK
COOK
OFIX
OFIX
Q4 25
$676.0M
$850.6M
Q3 25
$689.6M
$832.6M
Q2 25
$780.6M
$837.2M
Q1 25
$825.6M
$823.1M
Q4 24
$830.7M
$893.3M
Q3 24
$818.1M
$867.9M
Q2 24
$842.4M
$882.0M
Q1 24
$862.1M
$906.0M
Debt / Equity
COOK
COOK
OFIX
OFIX
Q4 25
2.36×
Q3 25
0.36×
Q2 25
0.34×
Q1 25
0.34×
Q4 24
1.46×
0.31×
Q3 24
0.23×
Q2 24
0.22×
Q1 24
0.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COOK
COOK
OFIX
OFIX
Operating Cash FlowLast quarter
$15.5M
$27.7M
Free Cash FlowOCF − Capex
$14.2M
$16.8M
FCF MarginFCF / Revenue
9.8%
7.6%
Capex IntensityCapex / Revenue
0.9%
4.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$13.6M
$-1.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COOK
COOK
OFIX
OFIX
Q4 25
$15.5M
$27.7M
Q3 25
$7.6M
$12.4M
Q2 25
$18.3M
$11.6M
Q1 25
$-20.8M
$-18.4M
Q4 24
$7.5M
$23.7M
Q3 24
$15.1M
$11.7M
Q2 24
$13.9M
$9.0M
Q1 24
$-12.6M
$-18.6M
Free Cash Flow
COOK
COOK
OFIX
OFIX
Q4 25
$14.2M
$16.8M
Q3 25
$6.4M
$2.5M
Q2 25
$15.7M
$4.5M
Q1 25
$-22.7M
$-25.1M
Q4 24
$5.5M
$15.2M
Q3 24
$12.8M
$6.3M
Q2 24
$11.8M
$-360.0K
Q1 24
$-18.3M
$-29.1M
FCF Margin
COOK
COOK
OFIX
OFIX
Q4 25
9.8%
7.6%
Q3 25
5.1%
1.2%
Q2 25
10.8%
2.2%
Q1 25
-15.8%
-13.0%
Q4 24
3.3%
7.0%
Q3 24
10.5%
3.2%
Q2 24
7.0%
-0.2%
Q1 24
-12.6%
-15.4%
Capex Intensity
COOK
COOK
OFIX
OFIX
Q4 25
0.9%
4.9%
Q3 25
0.9%
4.8%
Q2 25
1.8%
3.5%
Q1 25
1.3%
3.5%
Q4 24
1.2%
4.0%
Q3 24
1.9%
2.7%
Q2 24
1.2%
4.7%
Q1 24
3.9%
5.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COOK
COOK

Grills$60.6M42%
Accessories$49.2M34%
Consumables$35.5M24%

OFIX
OFIX

Spinal Implants Biologics And Enabling Technologies$113.6M52%
Bone Growth Therapies$68.3M31%
Other$22.7M10%
IT$5.9M3%
GB$3.5M2%
FR$3.5M2%
DE$2.3M1%

Related Comparisons